Effect of early tranexamic acid treatment on fatigue in patients with mild traumatic brain injury: data from the CRASH-3 clinical trial

Effect of early tranexamic acid treatment on fatigue in patients with mild traumatic brain injury: data from the CRASH-3 clinical trial

Background: Each year world-wide about 65 million people sustain a mild traumatic brain injury (mTBI). Fatigue is a common and distressing symptom after mTBI. We examine the effect of tranexamic acid (TXA) on fatigue in patients with mTBI using data from the CRASH-3 trial. Methods: The CRASH-3 trial...

Full description

Bibliographic Details
Published in:Wellcome Open Research
Main Author: Mansukhani R.; Belli A.; Brenner A.; Chaudhri R.; Frimley L.; Faizah Jamaluddin S.; Jooma R.; Shakur-Still H.; Shokunbi T.; Roberts I.
Format: Article
Language:English
Published: F1000 Research Ltd 2024
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85209990898&doi=10.12688%2fwellcomeopenres.17421.3&partnerID=40&md5=d4d360a38666674e9b6b733f5c0dde0d

Internet

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85209990898&doi=10.12688%2fwellcomeopenres.17421.3&partnerID=40&md5=d4d360a38666674e9b6b733f5c0dde0d

Similar Items